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Conclusions
• For three tonometers commonly used by UK community/primary 
care optometrists we found over half of measurements were within 
±2mmHg of GAT, with NCT having the greatest percentage of 
measurements within +-2mmHg. These findings concur with 
previous studies.4
• Pulsair and Icare recorded mean IOP lower than GAT, and there was 
a statistically significant difference between mean IOPs for Pulsair
vs GAT. Both these devices had wider 95% LoA than NCT. 
• Our results agreed with other researchers who found Icare to 
underestimate IOP7 more so when GAT ≥ 23mmHg.8
• Further work is needed to investigate the clinical impact of the 
choice of tonometer used in the detection of patients at risk of 
glaucoma, although IOP alone is not a good indicator of glaucoma.9
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• Agreement between NCT, Pulsair, Icare and GAT was assessed using Bland–
Altman difference analysis, and mean differences and 95% limits of 
agreement (LoA) of measurements calculated. 
• Percentages of IOP readings within ±2mmHg of the GAT reading were 
obtained.
Results
• Forty-one participants had their IOP measured by all four tonometers: 
median age 36 years (IQR: 20, 49), 71% female. 
• Figure 2 displays the Bland-Altman plots for each tonometer compared to 
GAT and the percentage of readings within ±2mmHg of GAT.
• Table 1 outlines the results for each tonometer compared to GAT.
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Tonometer Mean (SD) IOP 
(mmHg)
Mean Bias:
Tonometer-
GAT IOP 
(mmHg)
95% LoA
(mmHg)
P value
(F Test)
GAT 17.1 (3.7) - -
NCT 17.9 (3.2) 0.8 -5.4 to 6.9 0.21
Pulsair 15.4 (2.6) -1.7 -8.2 to 4.8 0.01
Icare 15.6 (4.2) -1.6 -9.0 to 5.9 0.22
Figure 2: Bland–Altman difference plots and % Agreement for NCT, Pulsair and Icare compared to GAT
Table 1 Comparison of each tonometer to GAT (95% LoA: Limits of Agreement)
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Introduction
• Cases of glaucoma in the UK are mostly identified through routine 
examinations by community/primary care optometrists.1,2
• Elevated Intraocular Pressure (IOP) is an important risk factor for 
glaucoma.3
• Goldmann Applanation Tonometry (GAT) is regarded as the 
reference method for IOP measurement.4
• UK community optometrists principally use non-contact or rebound 
tonometry to measure IOP.5,6 Knowledge of how these devices agree 
with GAT would help inform their choice of tonometer and 
potentially reduce the number of false positive referrals.
Purpose
• To assess the agreement of three tonometers commonly used by UK 
community optometrists with GAT. 
Methods
• Participants, 18 years and over, were recruited from a university eye 
clinic.
• IOP was measured by two research optometrists (RO1 and RO2), 
both experienced in GAT.
• IOP was first measured on the randomly selected study eye (SE1) 
using the three tonometers, NCT, Pulsair and Icare (Figure 1) by RO1. 
• GAT readings were then obtained in a masked manner by RO1. The 
force on the probe was initially set at a randomly selected value 
between 1g and 2g by RO2; RO1, masked to the dial reading, 
adjusted the probe until the end point, and RO2 recorded the 
measurement. 
Figure 1: Tonometers assessed for their agreement with GAT 
A: CT-1P Non-Contact Tonometer (NCT) (Topcon, Topcon Corporation, Tokyo, Japan). 
B: Pulsair IntelliPuff (Keeler Ltd., Windsor, UK). 
C: Icare rebound tonometer (Icare®, Helsinki, Finland).
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